Výsledky vyhledávání - "Jaime E Hernandez"

Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment

Autor: William P. Sheridan, Lone Simonsen, Joanne Grainger, Jaime E. Hernandez, Phil Collis, Laurel Edelman

Publikováno v: Influenza and Other Respiratory Viruses. 6:305-308

Analysis of a US hospitalization database demonstrated that more influenza patients were hospitalized and the age distribution of hospitalizations was younger during the 2009 (H1N1) influenza A pandemic compared with the three previous influenza seas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae9c99123633e09b8e1a9b091faef686
https://doi.org/10.1111/j.1750-2659.2011.00303.x

Zobrazit plný text záznamu

Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States

Autor: Robert W. Armstrong, Anna Wald, R. B. Adiga, Jose A. Bazan, Michael G. Ison, John S. Bradley, Jenna Elder, Hector Bonilla, William P. Sheridan, Robin H. Dretler, Jaime E. Hernandez, Julie E. Mangino, Alan S. Hollister, Christine Ziebold, Stacene R. Maroushek, Avinash K. Shetty

Publikováno v: Clinical Infectious Diseases. 52:695-706

(See the editorial commentary by Jain et al, on pages 707–709.) Background. Peramivir, an investigational intravenous neuraminidase inhibitor in Phase 3 trials for hospitalized patients, was made available during the 2009 H1N1 influenza pandemic un

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::12d3ec94a26704471693a3bb74204902
https://doi.org/10.1093/cid/cir001

Zobrazit plný text záznamu

Benefits, Risk, and Uncertainty: Preferences of Antiretroviral-Naïve African Americans for HIV Treatments

Autor: Albert Hauber, Ateesha F. Mohamed, Maria E. Watson, Jaime E. Hernandez, Faye M. Johnson

Publikováno v: AIDS Patient Care and STDs. 23:29-34

While African Americans in the United States are disproportionately affected by HIV, they are less likely to take antiretroviral therapies. Different first-line antiretroviral therapies are associated with short-term and long-term adverse event (AE)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d168a91756f9efddee489ebe2da9f3b
https://doi.org/10.1089/apc.2008.0064

Zobrazit plný text záznamu

Long-Term Safety and Tolerability of the Lamivudine/Abacavir Combination as Components of Highly Active Antiretroviral Therapy

Autor: Steve A Castillo, Jaime E Hernandez, Cindy H Brothers

Publikováno v: Drug Safety. 29:811-826

Background: Numerous large, long-term clinical trials have assessed the safety and efficacy of the two antiretroviral nucleoside analogs lamivudine and abacavir as components of highly active antiretroviral therapy for the treatment of patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84e478a607dfa86beb317b0209a7dbb1
https://doi.org/10.2165/00002018-200629090-00005

Zobrazit plný text záznamu

Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study

Autor: Douglas J. Ward, Michael Sension, Jaime E. Hernandez, J. Tyler Lonergan, Grace A. McComsey, Vanessa C. Williams, Siegrid M. Hessenthaler, Robin L. Fisher, Peter Shalit

Publikováno v: Clinical Infectious Diseases. 38:263-270

Stavudine use is a contributing factor for lipoatrophy, whereas use of abacavir or zidovudine is less likely to cause this complication. The TARHEEL study was a 48-week, open-label study that assessed changes in lipoatrophy after abacavir (86 patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba5cb3ddbcb37a349e3d27fa5346a7a6
https://doi.org/10.1086/380790

Zobrazit plný text záznamu

Safety/Tolerability and Efficacy of Abacavir-Containing Combination Therapy in HIV-1-Infected Adults in a Clinical Practice Setting: Results of ZORRO

Autor: Albert Canas, Siegrid M. Hessenthaler, Peter Ruane, Linda Yau, Gary Richmond, Marshall K. Kubota, Julio C. Arroyo, Cathy Alsop, Arthur L. Williams, Jaime E. Hernandez

Publikováno v: Infectious Diseases in Clinical Practice. 12:15-25

Information about the nucleoside analogue abacavir has been based primarily on the results of clinical trials, rather than on experience in the clinical practice setting. The Ziagen Optimal Regimen and Resistance Observational (ZORRO) trial was a Pha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9c9499f3ddb7a2c4a2ea27ddd1f0e602
https://doi.org/10.1097/01.idc.0000104895.16995.8d

Zobrazit plný text záznamu

Response to Lamivudine-Zidovudine plus Abacavir Twice Daily in Antiretroviral-Naive, Incarcerated Patients with HIV Infection Taking Directly Observed Treatment

Autor: David P. Paar, Karen T. Tashima, Margaret A. Fischl, Ginger Pittman, Siegrid M. Hessenthaler, Haitao Gao, Jacqueline R. Carranza Rosenzweig, Jaime E. Hernandez, Thomas Gensler, Neil M.H. Graham, Daniel R. McClernon, Larry R. Kirkland

Publikováno v: Clinical Infectious Diseases. 34:511-518

Prison inmates with human immunodeficiency virus (HIV) infection can be difficult to treat because of the complexity and intrusiveness of many combination antiretroviral therapy regimens. NZTA4007, a 24-week open-label, single-arm clinical trial invo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::189bc6bd39a37c96dc8800e9720127ba
https://doi.org/10.1086/338400

Zobrazit plný text záznamu

Stavudine-associated peripheral neuropathy in zidovudine-naïve patients: Effect of stavudine exposure and antiretroviral experience

Autor: Qiming Liao, Roger Anderson, Lisa L. Ross, Jaime E. Hernandez, Peter Shalit, Anthony Scarsella, Gregg Coodley, Robin L. Fisher

Publikováno v: Advances in Therapy. 19:1-8

A post hoc analysis of safety data from study protocol NZT40012 assessed the incidence of conditions defined by the Centers for Disease Control and Prevention in 86 zidovudine-naïve, antiretroviral-experienced patients with HIV-1 infection who respo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6a18152a7582bbfe5776ceedab1eb56
https://doi.org/10.1007/bf02850013

Zobrazit plný text záznamu

Intravenous peramivir for treatment of influenza in hospitalized patients

Autor: Brian J. O'Neil, Eduardo Sada-Diaz, Graham Mills, Barry Heller, Jaime E. Hernandez, Michael G. Ison, Jenna Elder, J. Douglass Rolf, Luis Jauregui, Joseph Fraiz, Phil Collis, E. Geoffrey Playford, William O'Riordan, William P. Sheridan

Publikováno v: Antiviral therapy. 19(4)

Background Influenza causes over 200,000 hospitalizations a year in the United States, but few antiviral treatment studies have focused on patients hospitalized with influenza. This open-label, randomized study was initiated during the 2009 H1N1 pand

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04adce91d4af80f6939c6ef51c47c470
https://pubmed.ncbi.nlm.nih.gov/23985625

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání